Immunome
IMNM60
$8.45arrow_drop_down0.76%-$0.06
High Growth
IMNM60
$8.45
arrow_drop_down0.76%Performance History
There's no data available for key stats
There's no data available for ratios/profitability stats
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Immunome (IMNM)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Purnanand Duddu Sarma Ph.D.
- Headquarters
- Exton
- Employees
- 37
- Exchange
- NASDAQ
Keep an eye on Immunome
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.